VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,983 | -10.6% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $39,143 | -6.9% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $42,055 | +10.7% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $38,000 | -51.9% | 1,300 | -60.6% | 0.00% | -50.0% |
| Q3 2022 | $79,000 | +54.9% | 3,300 | +73.7% | 0.00% | +100.0% |
| Q2 2022 | $51,000 | +2.0% | 1,900 | +46.2% | 0.00% | 0.0% |
| Q1 2022 | $50,000 | +19.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $42,000 | +10.5% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $38,000 | -19.1% | 1,300 | -7.1% | 0.00% | 0.0% |
| Q2 2021 | $47,000 | +4.4% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $45,000 | -84.6% | 1,400 | -82.7% | 0.00% | -87.5% |
| Q4 2020 | $292,000 | -29.6% | 8,100 | -23.6% | 0.01% | -33.3% |
| Q3 2020 | $415,000 | +6.7% | 10,596 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $389,000 | +18.2% | 10,596 | -25.9% | 0.01% | -7.1% |
| Q1 2020 | $329,000 | +100.6% | 14,296 | +155.5% | 0.01% | +133.3% |
| Q4 2019 | $164,000 | -24.8% | 5,596 | -31.3% | 0.01% | -33.3% |
| Q3 2019 | $218,000 | +137.0% | 8,146 | +126.5% | 0.01% | +125.0% |
| Q2 2019 | $92,000 | +318.2% | 3,596 | +259.6% | 0.00% | +300.0% |
| Q1 2019 | $22,000 | +4.8% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $21,000 | -12.5% | 1,000 | -21.9% | 0.00% | 0.0% |
| Q3 2018 | $24,000 | -14.3% | 1,280 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $28,000 | -84.3% | 1,280 | -84.3% | 0.00% | -83.3% |
| Q1 2018 | $178,000 | -65.4% | 8,130 | -63.2% | 0.01% | -33.3% |
| Q4 2017 | $514,000 | +103.2% | 22,100 | +100.0% | 0.01% | 0.0% |
| Q3 2017 | $253,000 | -27.1% | 11,050 | -29.6% | 0.01% | -25.0% |
| Q2 2017 | $347,000 | +59.2% | 15,700 | +63.5% | 0.01% | +71.4% |
| Q1 2017 | $218,000 | -76.8% | 9,600 | -78.7% | 0.01% | -75.0% |
| Q4 2016 | $941,000 | -32.9% | 44,990 | -15.2% | 0.03% | -31.7% |
| Q3 2016 | $1,403,000 | -10.3% | 53,040 | -6.0% | 0.04% | -8.9% |
| Q2 2016 | $1,564,000 | – | 56,420 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |